title: Saquinavir as Fortovase: why does it matter?
authors.affiliation: US Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Biologics Evaluation and Research, Bethesa, MD.
authors.forename: C B
authors.initials: CB
authors.lastname: Trapnell
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D019540:Area Under Curve; D001682:Biological Availability; D004304:Dosage Forms; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D019258:Saquinavir / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D004304:Dosage Forms; D017320:HIV Protease Inhibitors; D019258:Saquinavir